These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The proton magnetic resonance spectra of pentofuranose derivatives. Stevens JD; Fletcher HG J Org Chem; 1968 May; 33(5):1799-805. PubMed ID: 5655927 [No Abstract] [Full Text] [Related]
46. Preparation of diastereomeric urethane derivatives of atropine and l-hyoscyamine using (-)-1-phenylethylisocyanate. Landen WO; Caine DS J Pharm Sci; 1979 Aug; 68(8):1039-41. PubMed ID: 480159 [TBL] [Abstract][Full Text] [Related]
47. Solvent effects in the NMR spectra of cyano compounds. Smissman EE; Makriyannis AC J Pharm Sci; 1970 Aug; 59(8):1186-7. PubMed ID: 5457343 [No Abstract] [Full Text] [Related]
48. Studies on 1,2,3,4-tetrahydroisoquinolines. IV. beta-Adrenoceptor activity and absolute stereochemistry of (-)-5,7-dihydroxy-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline. Yamada K; Takeda M; Itoh N; Umino N; Ikezawa K; Kiyomoto A; Aoe K; Kotera K; Iwakuma T Chem Pharm Bull (Tokyo); 1982 May; 30(5):1588-93. PubMed ID: 6288275 [No Abstract] [Full Text] [Related]
49. Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man. Sandler M; Carter SB; Hunter KR; Stern GM Nature; 1973 Feb; 241(5390):439-43. PubMed ID: 4705752 [No Abstract] [Full Text] [Related]
50. II. Sequence effects in the high-resolution NMR spectra of oligonucleotides. A. Oligoadenylate spectra. ANL-7409. Hruska FE; Umemoto K; Danyluk SS ANL Rep; 1967; ():19-21. PubMed ID: 5308244 [No Abstract] [Full Text] [Related]
52. [Syntheses and ring-closures of difunctional tetrahydroisoquinolines]. Zalán Z Acta Pharm Hung; 2006; 76(3):155-64. PubMed ID: 17094664 [TBL] [Abstract][Full Text] [Related]
53. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands. Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994 [TBL] [Abstract][Full Text] [Related]
54. Studies on the proton magnetic resonance spectra in aromatic systems. I. Discussions on the para-disubstituted-1-substituted-3,4-dimethoxy- and 1-substituted-3,4-methylenedioxy benzene derivatives. Sasaki Y; Suzaki M; Hibino T; Karai K Chem Pharm Bull (Tokyo); 1967 May; 15(5):599-607. PubMed ID: 6076758 [No Abstract] [Full Text] [Related]
55. Structural assignment of an N-glucuronide metabolite of the phenylethanolamine N-methyltransferase (PNMT) inhibitor 1,2,3,4-tetrahydroisoquinoline-7-sulfonamide by 15N-NMR. Kuo GY; Hwang BY; Staiger DB Biochem Pharmacol; 1986 May; 35(9):1613-5. PubMed ID: 3707623 [No Abstract] [Full Text] [Related]
56. [Studies on ring-opening of heterocyclic compounds. IV. Alternative preparation of N-substituted iminopyridinium and N-substituted iminoisoquinolinium betaines]. Tamura Y; Tsujimoto N; Uchimura M Yakugaku Zasshi; 1971 Jan; 91(1):72-80. PubMed ID: 5101919 [No Abstract] [Full Text] [Related]
57. [Protonation of amino and hydroxypyrimidines. NMR-spectra and structures of mono and dications]. Wagner R; von Philipsborn W Helv Chim Acta; 1970; 53(2):299-320. PubMed ID: 5435977 [No Abstract] [Full Text] [Related]
58. 13C-NMR spectra of strychnos alkaloids: brucine and strychnine. Singh SP; Stenberg VI; Parmar SS; Farnum SA J Pharm Sci; 1979 Jan; 68(1):89-92. PubMed ID: 31454 [TBL] [Abstract][Full Text] [Related]